HC Wainwright reaffirmed their buy rating on shares of TransCode Therapeutics (NASDAQ:RNAZ – Free Report) in a research note published on Thursday morning, Benzinga reports. HC Wainwright currently has a $3.00 price objective on the stock. TransCode Therapeutics Stock Performance RNAZ stock opened at $1.15 on Thursday. The stock’s 50 day moving average price is […]
Cogent Biosciences (NASDAQ:COGT – Get Free Report) and TransCode Therapeutics (NASDAQ:RNAZ – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk. Analyst Ratings This is a breakdown of […]
TransCode Therapeutics Open Letter to Shareholders tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today? biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.